From: The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study
 | Sex | |||
---|---|---|---|---|
 | Males | Females | ||
First primary cancer | Obs. | SIR (95% CI) | Obs. | SIR (95% CI) |
   Head and neck | 1,620 | 1.70 (1.62-1.79) | 369 | 1.84 (1.66-2.04) |
   Oesophagus | 78 | 1.43 (1.13-1.79) | 27 | 1.06 (0.70-1.54) |
   Stomach | 150 | 0.83 (0.70-0.98) | 56 | 1.00 (0.75-1.30) |
   Colorectal | 1,899 | 1.04 (0.99-1.08) | 1,147 | 1.08 (1.02-1.15) |
   Pancreas | 31 | 0.92 (0.63-1.31) | 18 | 0.85 (0.50-1.34) |
   Lung | 552 | 1.18 (1.08-1.28) | 177 | 1.41 (1.21-1.64) |
   Melanoma | 3,267 | 1.77 (1.71-1.83) | 1,825 | 1.70 (1.62-1.78) |
   Breast - female | n.a. | n.a. | 2,962 | 1.31 (1.27-1.36) |
   Cervix | n.a. | n.a. | 300 | 1.36 (1.21-1.52) |
   Uterus | n.a. | n.a. | 409 | 1.16 (1.05-1.28) |
   Ovary | n.a. | n.a. | 164 | 1.12 (0.95-1.30) |
   Prostate | 3,006 | 0.83 (0.80-0.86) | n.a. | n.a. |
   Kidney | 434 | 1.39 (1.27-1.53) | 221 | 1.69 (1.47-1.93) |
   Bladder | 1,370 | 1.40 (1.33-1.48) | 310 | 1.61 (1.43-1.79) |
   Brain & CNS | 31 | 1.05 (0.71-1.49) | 19 | 0.94 (0.57-1.47) |
   Thyroid | 70 | 1.47 (1.15-1.86) | 145 | 1.35 (1.14-1.59) |
   Non-Hodgkin lymphoma | 411 | 1.37 (1.24-1.51) | 278 | 1.36 (1.20-1.53) |
   Lymphoid leukaemia | 297 | 1.66 (1.48-1.86) | 125 | 1.40 (1.17-1.67) |
   Myeloid leukaemia | 87 | 1.44 (1.15-1.77) | 38 | 1.25 (0.88-1.71) |
   Myeloma/PCT | 93 | 1.04 (0.84-1.27) | 41 | 0.89 (0.64-1.21) |
   Other | 992 | 1.23 (1.16-1.31) | 561 | 1.37 (1.26-1.49) |
   All cancers combined | 14,388 | 1.22 (1.20-1.24) | 9,192 | 1.36 (1.33-1.39) |